FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Eini Meir

2. Date of Event Requiring Statement (MM/DD/YYYY)
1/1/2018 

3. Issuer Name and Ticker or Trading Symbol

Foamix Pharmaceuticals Ltd. [FOMX]

(Last)        (First)        (Middle)

2 HOLTZMAN STREET

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                            _____ 10% Owner
_____ Officer (give title below)          ___ X ___ Other (specify below)
/ Observer to Board of Directors

(Street)

REHOVOT, L3 7670402       

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed (MM/DD/YYYY)

 

6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person


Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Ordinary Shares   2757781   I   See footnote   (1)
Ordinary Shares   11239   D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Warrants   5/13/2014   5/13/2018   Ordinary Shares   20860   $5.04   I   See footnote   (1)
Options     (2) 12/29/2024   Ordinary Shares   48000   $5.88   D    
Options     (3) 12/29/2024   Ordinary Shares   36000   $6.77   D    
Options     (4) 8/9/2026   Ordinary Shares   35000   $7.09   D    
Options     (5) 1/1/2027   Ordinary Shares   60389   $10.3   D    
Restricted Share Units     (6)   (6) Ordinary Shares   5625   $0.00   D    
Restricted Share Units     (7)   (7) Ordinary Shares   20000   $0.00   D    
Restricted Share Units     (8)   (8) Ordinary Shares   20130   $0.00   D    

Explanation of Responses:
(1)  Shares and Warrants held by Meir Eini Holdings Ltd., an Israeli company controlled by Meir Eini
(2)  The Options vested over a period of three years from December 29, 2014 (33.3% on each anniversary of such date) and ending December 29, 2017
(3)  The Options vest over a period of four years from December 29, 2014 (25% on the first anniversary of such date and 6.25% every three months thereafter) and ending December 29, 2018
(4)  The Options vest over a period of four years from August 9, 2016 (25% on the first anniversary of such date and 6.25% every three months thereafter) and ending August 9, 2020
(5)  The Options vest over a period of four years from January 1, 2017 (25% on the first anniversary of such date and 6.25% every three months thereafter) and ending January 1, 2021
(6)  The Restricted Share Units vest in equal installments every three months beginning on January 15, 2018 and ending January 15, 2019
(7)  The Restricted Share Units vest on November 15, 2018
(8)  The Restricted Share Units vest over a period of four years (25% on January 1, 2018 and 6.25% every three months thereafter) ending January 1, 2021

Remarks:
The Reporting Person is filing this form in connection with the Issuer's transition from a foreign private issuer to a domestic issuer, effective January 1, 2018. Exhibit 24 Power of Attorney

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Eini Meir
2 HOLTZMAN STREET
REHOVOT, L3 7670402



Observer to Board of Directors

Signatures
/s/ Ilan Hadar as attorney-in-fact for Meir Eini 1/18/2018
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Foamix Pharmaceuticals (NASDAQ:FOMX)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Foamix Pharmaceuticals Charts.
Foamix Pharmaceuticals (NASDAQ:FOMX)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Foamix Pharmaceuticals Charts.